News

The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China
Grand Pharmaceutical Group Limited (0512.HK, "Grand Pharma" or the "Group") announces that the Phase II clinical study for the treatment of sepsis in China of the global innovative drug STC3141, which ...
Medpage Today on MSN2mon
Aspirin for Sepsis Flops in Trial
For the primary endpoint -- mean change in Sequential Organ Failure Assessment (SOFA) score between day 0 and 7 or the day of ...